The National Institutes of Health (NIH) has renewed Vanderbilt University Medical Center’s membership in NeuroNEXT, a research network that helps streamline Phase 2 clinical trials for brain disorders.

June 29, 2018 - Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may possibly delay the progression of one of the cardinal features of Parkinson’s disease.

A sleep apnea diagnosis can often be the start to a healthier and better life.

The Vanderbilt Multiple Sclerosis Center has opened a relapse clinic that offers expedited access for patients experiencing disease flare-ups.

The APOE gene, the strongest genetic risk factor for Alzheimer’s disease, may play a more prominent role in disease development among women than men, according to new research from the Vanderbilt Memory and Alzheimer’s Center.

The leaders of a new Vanderbilt initiative for young adults with autism are looking to expand its reach through distance learning. Launched a year ago to primarily serve Middle Tennessee residents, Spectrum Pathways has generated out-of-state interest with some participants flying into Nashville to take part.

Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.